Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study.
Hadjadj J, Wolfers A, Borisov O, Hazard D, Leahy R, Jeanpierre M, Belot A, Bakhtiar S, Hauck F, Lee PY, Volpi S, Palmeri S, Barlogis V, Aladjidi N, Ebetsberger-Dachs G, Avouac J, Charbit-Henrion F, Cheminant M, Donadieu J, Ghosh S, Hoytema van Konijnenburg DP, Körholz J, Bustamante J, Rosain J, Forbes Satter L, Selmeryd I, Sogkas G, Neven B, Rieux-Laucat F, Ehl S; SOCS1 Study Group.
Hadjadj J, et al.
Lancet Rheumatol. 2025 Jun;7(6):e391-e402. doi: 10.1016/S2665-9913(24)00348-5. Epub 2025 Feb 27.
Lancet Rheumatol. 2025.
PMID: 40024253